Also, your big bac t company has 7700 employees but can't do AST (antibiotic susceptibility testing) in a timely fashion. The future of bac t will not only require the rapid detection and correct ID of bacteria, but also the correct antibiotic selection within the first 8 hours of detection. Your BIG bac t company can't achieve that if it relies on molecular ID, since that method kill the bug before the AST is commenced. Only the AXDX technology does that. Look to AXDX to become the new standard of care.